As per an analysis, India’s share in the USA’s electronics exports has increased to 7.2 per cent to 3.5 per cent year-on-year in May, while China’s share dipped to 11 per cent from 22 per cent during the same period.
Within electronics the growth for India was led by smartphones and solar cells. Overall electronics exports in April-June were up 47 per cent to USD 12.41 billion.
Similarly, China’s share in textiles exports to the US fell from 27 per cent to 14 per cent, at a time when India’s share in the US textiles’ import market grew from 9 per cent to 12 per cent and Vietnam’s share grew from 14 per cent to 18 per cent.
In the agriculture and marine products sector, China’s share to America has dipped from 3.5 per cent to 1.5 per cent, and despite no overlap in export commodities, India’s share has grown from 1.7 per cent to 2.2 per cent.
Indonesia and Vietnam ended up grabbing a portion of China’s space in agriculture exports to the US. The official also said that in the first quarter of 2025-26, India, Mexico and the European Union (EU) have witnessed a positive growth in exports to the US, while China has seen the sharpest fall in exports to the US among G20 countries (around 5 per cent), followed by Canada and many other countries. China’s exports to the US have suffered as it has faced the highest tariffs among major exporters to America. Even after the agreement between the US and China the tariffs on China stay at 55 per cent.
On the other hand, Indian goods attract an additional 10 per cent duty in the US markets. Besides, there is 50 per cent duty on steel and aluminium, and 25 per cent on auto and auto parts.
According to experts, these high sector duties may have implications for India.
As steel and aluminum have 50 per cent additional duties, the domestic steel prices in the US are 40 per cent more than international prices. This high price and tariff uncertainty has resulted in fall in order inflow.
Another sector that has suffered due to tariff uncertainty is chemicals. India’s share of US import of chemicals has come down to 3.5 per cent from 4.4 per cent between May 2024 and May 2025.
As pharma tariffs have been left untouched so far, India is maintaining its share in the US market.
India maintains 40 per cent share of the US generic drugs imports.
US President Donald Trump has threatened 200 per cent duties on pharma but India is expected to maintain its share as its products are 30 per cent to 80 per cent cheaper than the competition.
